Área de Salud de Cáceres
Gerencia del Área de Salud de Cáceres

Publicaciones Científicas- Líneas de Investigación

Publicaciones Científicas

1. Perez-G M., M. Melo, A.D. Keegan, and J. Zamorano. 2002. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J. Immunol. 168:1428-1434.

2. Zamorano, J., M.D. Rivas, A. Garcia-Trinidad, C.K. Qu, and A.D. Keegan. 2003. Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6. J. Immunol. 171:4203-4209.

3. Zamorano J., M.D. Rivas, F. Setien, and M. Perez-G. 2005. Proteolytic regulation of activated STAT6 by calpains. J. Immunol. 174:2843-2848.

4. Sanchez de Cos, J., D. Masjoans, M.A. Sojo, J. Zamorano, C. Disdier, and M. C. Perez. 2007. Metástasis encefálicas silentes en la estadificación inicial del cáncer de pulmón. Evaluación mediante tomografía computarizada y resonancia magnética. Arch Bronconeumol. 43:386-391

5. Cortes J.R., M. Perez-G, M.D. Rivas, and J. Zamorano. 2007. Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3. J Immunol. 179:3881-3887.

6. Perez-G, M., J.R. Cortes, M.D. Rivas, F. Masa, and J. Zamorano. 2008. Treatment of cells with n-alpha-tosyl-L-phenylalanine-chloromethyl ketone induces the proteolytic loss of STAT6 transcription factor. Mol Immunol. 45:3896-3901.

7. Masa J.F., J. Corral., J. Teran,. M.J. Martin, C. Disdier, M. Rubio, M. Mota, J. Zamorano, and J.M. Montserrat. 2009. Apnoeic and obstructive non-apnoeic sleep respiratory events. Eur Respir J 34:156-161.

8. Cortes, J.R., M.D. Rivas, J. Molina-Infante, M.A. Gonzalez-Nuñez, M. Perez-G, J.F. Masa, J.F. Sanchez, and J. Zamorano. 2009. Omeprazole inhibits IL-4 and IL-13 signaling STAT6 activation and reduces lung inflammation in murine asthma. J Allergy Clin Immun 124:607-610, 610e1.

9. Molina-Infante, J., and J. Zamorano. 2009.Acid-Suppressive Therapy and Eosinophilic Esophagitis: Friends or Foes ? Am J Gastroenterol doi:10.1038/ajg.2009.590.

10. Sanchez Muñoz-Torrero, J.F., D. Escudero, C. Suarez, C. Sanclemente, M.T. Pascual, J. Zamorano, M. Monreal and the FRENA Investigators. 2009.Concomitant use of proton-pump inhibitors and clopidogrel in patients with coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry. Submitted.

11. J. Molina-Infante, L. Ferrando-Lamana. Eosinophilic esophagitis misdiagnosed twice for esophageal candidiasis. Gastrointest Endosc 2010; in press

12. J. Molina-Infante, L. Ferrando-Lamana, Miguel Fernandez-Bermejo, S Porcel-Carreño. Eosinophilic esophagitis in GERD patients: a clinicopathologic diagnosis using proton pump inhibitors. Am J Gastroenterol 2009;104:2856-7.

13. 7. J. Molina Infante, B. Pérez Gallardo, M. Hernández Alonso, J.M. Mateos Rodríguez, C. Dueñas Sadornil, M. Fernández Bermejo. Octreotide LAR for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities. Med Clin (Barc) 2009; 33(17):667-70.

14. J. Molina Infante, J. Bergua Burgues, N. Fernandez Gonzalez. Diarrhoea caused by colonic relapse of follicular lymphoma. Brit J Haematol 2009;146:466.

15. Gisbert JP, Bermejo MF, Infante JM, Gallardo BP, Bermejo AB, Rodríguez JM, Andrés PR, García GG. Levofloxacin, Amoxicillin, and Omeprazole as First-line Triple Therapy for Helicobacter pylori Eradication. J Clin Gastroenterol 2009;43:384-5.

16. J. Molina Infante, M. Hernandez Alonso, B. Pérez Gallardo, E. Martin Noguerol. The first Asian case report of eosinophilic esophagitis in an asymptomatic adult: what about a proton pump inhibitor trial?. J Chin Med Assoc 2009;72:166-7.

17. J. Molina Infante, M. Hernández Alonso. Hepatobiliary and pancreatic: malignant gallbladder polyp. J Gastroenterol Hepatol 2008;23:1622.

18. J. Molina Infante, L. Ferrando Lamana, JM Mateos Rodriguez, B. Perez Gallardo, AB Prieto Bermejo. Overlap of reflux and eosinophilic esophagitis in two patients requiring different therapies: review of the litarature. World J Gastroenterol 2008;14:1463-6.

19. JP Gisbert, M. Fernández Bermejo, J. Molina Infante, B. Pérez Gallardo, A.B. Prieto Bermejo, J.M. Mateos Rodríguez, P. Robledo Andrés, G. Gonzalez García. First line triple therapy with levofloxacin for Helicobacter Pylori eradication. Aliment Pharmacol Ther 2007;26:495-500.

20. J. Molina Infante, B. Pérez Gallardo, G. Gonzalez Garcia, M. Fernandez Bermejo, JM Mateos Rodríguez, P. Robledo Andres. Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy. Gut 2007;56:447.

21. Zárate R, González-Santigo S, de la Haba J, Bandres E, Morales R, Salgado J, Gómez A, Aranda E, García-Foncillas J. GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment. Current Drug Metabolism 2007 Jun; 8(5): 481-6.

22. Monreal M, Sánchez JF, Naraine VS, Jiménez D, et al. Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. Findings form the RIETE registry. Am J Med 2006; 119: 851-858.

23. C Falga, J A Capdevila, S Soler, R Rabuñal, J F Sanchez, P Gallego. M Monreal.Clinical Outcome of Patients with Venous Thromboembolism and Renal Insufficiency. Findings from the RIETE Registry. Thromb Haemost 2007;98:771-6.

24. N. R. Robles, J. F. Sánchez Muñoz-Torrero, F. Garcia Gallego, J. Velasco Gemio, J. M. Escola. Homocysteinemia in Hypertensive Patients with Renal Target Organ Damage (Mild Renal Dysfunction) Eur J Med Res 2008; 13: 1-4